Brain Tumors Research Today is a free monthly online journal that collates and summarizes the latest research about Brain Tumors, including details on symptoms, benign and malignant tumors, gliomas, screening, treatment.

Volume 2 (2005), Issue 9 (September)

1. Current management of brain metastases, with a focus on systemic options.
   J Clin Oncol, 23(25): 6207-19. [Abstract] [Full-text]
2. Etoposide, vincristine, and cyclosporin A with standard-dose radiation therapy in newly diagnosed diffuse intrinsic brainstem gliomas: a pediatric oncology group phase I study.
   Pediatr Blood Cancer, 45(5): 644-8. [Abstract] [Full-text]
3. Patterns of treatment failure in infants with primitive neuroectodermal tumors who were treated on CCG-921: a phase III combined modality study.
   Pediatr Blood Cancer, 45(5): 676-82. [Abstract] [Full-text]
4. Unilateral profound hearing loss and the effect on quality of life after cerebellopontine angle surgery.
   Otolaryngol Head Neck Surg, 133(3): 339-46. [Abstract] [Full-text]
5. Cyclosporine a induces growth arrest or programmed cell death of human glioma cells.
   Neurochem Int, 47(6): 430-41. [Abstract] [Full-text]
6. Cutaneous metastasis from glioblastoma.
   Br J Neurosurg, 19(1): 65-8. [Abstract] [Full-text]
7. Spontaneous transdural spread of glioblastoma with atypical presentation.
   Br J Neurosurg, 19(1): 61-5. [Abstract] [Full-text]
8. A spectrum of behaviour in silent corticotroph pituitary adenomas.
   Br J Neurosurg, 19(1): 38-42. [Abstract] [Full-text]
9. Real-time functional magnetic resonance imaging (rt-fMRI) in patients with brain tumours: preliminary findings using motor and language paradigms.
   Br J Neurosurg, 19(1): 25-32. [Abstract] [Full-text]
10. Absence of adrenocorticotropin (ACTH) neurosecretory dysfunction but increased cortisol concentrations and production rates in ACTH-replete adult cancer survivors after cranial irradiation for nonpituitary brain tumors.
    J Clin Endocrinol Metab, 90(9): 5217-25. [Abstract] [Full-text]
11. Is there a role for ghrelin and peptide-YY in the pathogenesis of obesity in adults with acquired structural hypothalamic damage?
    J Clin Endocrinol Metab, 90(9): 5025-30. [Abstract] [Full-text]
12. Detection of adrenocorticotropin-secreting pituitary adenomas by magnetic resonance imaging in children and adolescents with cushing disease.
    J Clin Endocrinol Metab, 90(9): 5134-40. [Abstract] [Full-text]
13. Receptors and sites of synthesis and storage of gamma-aminobutyric acid in human pituitary glands and in growth hormone adenomas.
    Am J Clin Pathol, 124(4): 550-8. [Abstract] [Full-text]
14. Survivin expression in intracranial ependymomas and its correlation with tumor cell proliferation and patient outcome.
    Am J Clin Pathol, 124(4): 543-9. [Abstract] [Full-text]
15. Genetic alteration and expression of the phosphoinositol-3-kinase/Akt pathway genes PIK3CA and PIKE in human glioblastomas.
    Neuropathol Appl Neurobiol, 31(5): 486-90. [Abstract] [Full-text]
16. Immunohistochemical estimation of cell cycle entry and phase distribution in astrocytomas: applications in diagnostic neuropathology.
    Neuropathol Appl Neurobiol, 31(5): 455-66. [Abstract] [Full-text]
17. Clinicopathologic significance of cystatin C expression in gliomas.
    Hum Pathol, 36(9): 1008-15. [Abstract] [Full-text]
18. Amplification of genes encoding KIT, PDGFRalpha and VEGFR2 receptor tyrosine kinases is frequent in glioblastoma multiforme.
    J Pathol, 207(2): 224-31. [Abstract] [Full-text]
19. Metabolic differences between primary and recurrent human brain tumors: a 1H NMR spectroscopic investigation.
    NMR Biomed, 18(6): 371-82. [Abstract] [Full-text]
20. Angiogenesis of glioma: evaluation of ultrastructural characteristics of microvessels and tubular bodies (Weibel-Palade) in endothelial cells and immunohistochemical findings with VEGF and p53 protein.
    Med Mol Morphol, 38(1): 36-42. [Abstract] [Full-text]
21. Phenotype dependent differential effects of interleukin-1beta and amyloid-beta on viability and cholinergic phenotype of T17 neuroblastoma cells.
    Neurochem Int, 47(7): 466-73. [Abstract] [Full-text]
22. Detection of intracellular lactate with localized diffusion {1H-13C}-spectroscopy in rat glioma in vivo.
    J Magn Reson, 177(1): 129-38. [Abstract] [Full-text]
23. Inter-alu PCR detects high frequency of genetic alterations in glioma cells exposed to sub-lethal cisplatin.
    Int J Cancer, 117(4): 683-9. [Abstract] [Full-text]
24. Autoantibodies against GLEA2 and PHF3 in glioblastoma: tumor-associated autoantibodies correlated with prolonged survival.
    Int J Cancer, 117(3): 456-9. [Abstract] [Full-text]
25. Distribution, characterization and significance of polyomavirus genomic sequences in tumors of the brain and its covering.
    J Med Virol, 77(3): 447-54. [Abstract] [Full-text]
26. hERG1 channels are overexpressed in glioblastoma multiforme and modulate VEGF secretion in glioblastoma cell lines.
    Br J Cancer, 93(7): 781-92. [Abstract] [Full-text]
27. Perioperative management of patients undergoing transsphenoidal pituitary surgery.
    Anesth Analg, 101(4): 1170-81. [Abstract] [Full-text]
28. A multicentre prospective collection of newly diagnosed glioblastoma patients in Lombardia, Italy.
    Neurol Sci, 26(4): 227-34. [Abstract] [Full-text]
29. Phase I trial of temozolomide plus O6-benzylguanine for patients with recurrent or progressive malignant glioma.
    J Clin Oncol, 23(28): 7178-87. [Abstract] [Full-text]

© 2004-2010 Brain Tumors Research Today. All Rights Reserved.